The Effects of Disease Activity and Interferon-beta on Telomere Length and Telomerase Activity in Multiple Sclerosis

被引：0
|
作者：
Wakerley, Benjamin R.
Nicholas, Richard S.
Malik, Omar R.
Altmann, Daniel M.
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A135 / A135
页数：1
相关论文
共 50 条
  • [41] Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis
    Aravindan, Ananthakrishnapuram
    Yong, Jim
    Killingsworth, Murray
    Suranyi, Michael
    Wong, Jeffrey
    CLINICAL KIDNEY JOURNAL, 2010, 3 (02): : 132 - 134
  • [42] Interferon-beta in multiple sclerosis causing thrombotic microangiopathy
    Yam, Charmaine
    Fok, Anthony
    Mclean, Catriona
    Butler, Ernest
    Kempster, Peter
    INTERNAL MEDICINE JOURNAL, 2019, 49 (02) : 274 - +
  • [43] Interferon-beta therapy in multiple sclerosis: Early or late
    Limmroth, V
    Kastrup, O
    AKTUELLE NEUROLOGIE, 2003, 30 (01) : 3 - 9
  • [44] COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS
    Salvatore, Elena
    Morra, Vincenzo Brescia
    Orefice, Giuseppe
    NEUROLOGY, 2009, 73 (13) : 1078 - 1078
  • [45] COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS
    Markovic-Plese, Silva
    Jewells, Valerie
    Speer, Danielle
    NEUROLOGY, 2009, 72 (22) : 1965 - 1965
  • [46] Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
    Birnbaum, G.
    Cree, B.
    Altafullah, I.
    Zinser, M.
    Reder, A. T.
    NEUROLOGY, 2008, 71 (18) : 1390 - 1395
  • [47] Interferon-beta 1a in the treatment of multiple sclerosis
    Hartung, HP
    NERVENARZT, 1997, 68 (06): : 525 - 527
  • [48] Relationship between Physical Activity Level, Telomere Length, and Telomerase Activity
    Ludlow, Andrew T.
    Zimmerman, Jo B.
    Witkowski, Sarah
    Hearn, Joe W.
    Hatfield, Bradley D.
    Roth, Stephen M.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (10): : 1764 - 1771
  • [49] Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta
    Mayorga, C
    Luque, G
    Romero, F
    Guerrero, R
    Blanca, M
    Fernandez, O
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) : 368 - 371
  • [50] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products
    Grossberg, S. E.
    Gehshan, A.
    Long, C.
    Chuppa, S. L.
    Nicholson, K.
    Grossberg, L. D.
    MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
12345